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Abstract  
In 1972 Archie Cochrane wrote “It is surely a great criticism of our profession that we have 
not organised a critical summary, by specialty or subspecialty, adapted periodically, of all 
relevant randomised controlled trials”. The Cochrane Collaboration arose in response to 
Archie Cochrane’s challenge. Cochrane Eyes and Vision aims to prepare and promote access 
to systematic reviews of interventions for preventing or treating eye conditions and/or 
visual impairment, and helping people adjust to visual impairment or blindness. To identify 
all relevant randomised controlled trials, Cochrane Eyes and Vision has a team of 
information specialists who develop search strategies to identify studies for inclusion in 
Cochrane reviews. Since 1997 we have published 266 protocols, 193 new reviews and 158 
updated reviews. The majority of these are reviews of intervention effectiveness; three 
reviews are diagnostic test accuracy reviews. Overall 18% of reviews contain no trials, 
highlighting a potential evidence gap. We provide training, education and guidance to 
systematic review authors and work with clinical and patient partners to prioritise and 
disseminate reviews. In addition, Cochrane Eyes and Vision US satellite carries out critical 
methodologic research addressing topics relevant to producing high quality reviews. We are 
partnering with the journal Eye to publish commentaries on selected Cochrane systematic 
review findings. This partnership will allow us to make high quality evidence available to 
ophthalmologists and other practitioners, researchers, policy makers and patients.  
Background to Cochrane 
In 1972 Archie Cochrane wrote “It is surely a great criticism of our profession that we have 
not organised a critical summary, by specialty or subspecialty, adapted periodically, of all 
relevant randomised controlled trials” [1]. The Cochrane Collaboration arose as a response 
to Archie Cochrane’s challenge. Iain Chalmers set out the principles behind the Cochrane 
Collaboration in 1993 [2]. He highlighted the fact that it is difficult for people making 
decisions about health care to find all relevant information and they must rely on reviews of 
the evidence. Chalmers argued that reviews occupy a key link between research and 
improved outcomes of health care and that they should be conducted using scientific 
principles and regularly updated.  
Chalmers recognised that the only way to achieve this huge task was to make collaboration 
a key feature of the effort. At an early stage, the Cochrane Collaboration was organised 
around the principle of the “collaborative review group”, a group of individuals with a 
shared interest in a particular area of health care. Another important early decision was to 
publish the work of the Cochrane Collaboration electronically, thus making it easier to keep 
each review up to date and to ensure that any errors can be corrected quickly.  
The Cochrane Collaboration has driven the development of methods for evidence synthesis 
[3].  In particular, risk of bias tools for randomised controlled trials [4], for non-randomised 
studies [5] and the use of GRADE to assess the certainty of the evidence [6] with 
incorporation of summary of findings tables with input from users of the information [7]. 
The methods used in Cochrane reviews are summarised in the Cochrane Handbook and are 
freely available online (training.cochrane.org/handbook). Cochrane has also developed a 
core set of methodological expectations based on the Cochrane handbook 
(methods.cochrane.org/mecir). As a result of this international collaborative activity on 
methods, Cochrane reviews are usually judged to be higher quality than other reviews [8 9].   
Cochrane Eyes and Vision  
The Cochrane Eyes and Vision collaborative review group was registered in 1997. Cochrane 
Eyes and Vision contributes systematic reviews of the effects of interventions for visual 
impairment and eye disease to The Cochrane Library (www.eyes-cochrane.org). Box 1 
presents an explanation of the key features of a systematic review. We have contributors 
from all around the world with over 1,000 authors and approximately 400 peer reviewers 
predominantly from the UK, USA, China, Australia, Italy, Brazil, Mexico and India.  
[Box 1 here] 
Cochrane Eyes and Vision identifies the evidence, provides training and education to people 
who undertake systematic reviews (the clinical community and others), provides guidance 
to authors undertaking systematic reviews, and works with clinical and patient partners to 
prioritise and disseminate reviews.  The editorial base for the group is located at the London 
School of Hygiene and Tropical Medicine (LSHTM) in the UK and is funded by the UK 
National Institute for Health Research (NIHR).  The UK editorial base is responsible for the 
publication of Eyes and Vision reviews in The Cochrane Library.   
The group has two satellites.  The Cochrane Eyes and Vision US satellite, located at Johns 
Hopkins Bloomberg School of Public Health in Baltimore, Maryland, has been funded by the 
National Eye Institute of the National Institutes of Health since 2002. The overall objective 
of the US satellite is to develop a critical mass of US-based vision researchers and 
practitioners who are trained in preparing and using systematic reviews as part of Cochrane 
Eyes and Vision. In addition to identifying the evidence, and educating and guiding the 
workforce, the US satellite focuses on providing a centre for comparative effectiveness 
research and performs methodological research needed to improve the quality of 
systematic reviews.    
The Diagnostic Test Accuracy (DTA) satellite is based at the University of Florence, Italy. The 
DTA satellite provides specific support for DTA reviews which have a different structure 
compared with intervention reviews and are more complex to conduct. They require 
specific statistical and methodological tools and, above all, a discussion on the clinical 
pathway and the decision context where the test under investigation is used. The largest 
DTA review published by the satellite includes 106 studies investigating the accuracy of 
imaging tests for diagnosing manifest glaucoma [10].  
Cochrane has recently developed networks of CRGs. CEV is in the Skin, Sensory and 
Musculoskeletal network (https://www.cochrane.org/about-us/our-global-
community/review-group-networks).  
Cochrane Eyes and Vision Output 1997 to 2018 
Identifying the evidence  
CEV has a team of information specialists who develop search strategies to identify studies 
for inclusion in Cochrane reviews. A register of reports of randomised controlled trials 
(RCTs) is maintained and is available by searching the Cochrane Central Register of 
Controlled Trials (CENTRAL) in The Cochrane Library. We also search specific journals 
manually to identify additional reports of RCTs and these results are added to CENTRAL. 
Cochrane has developed a machine-learning classifier to identify RCTs [11]. CEV information 
specialists assess the ophthalmic related results from the classifier and provide feedback on 
the accuracy of the search algorithm. 
Reviews and protocols 
The first Cochrane Eyes and Vision review was published in 1998 and examined the role of 
antioxidant vitamins and minerals in the progression of age-related macular degeneration 
and included 3 randomized trials. The 10th update of this review was published in 2017 [12] 
and now includes 20 published trials. Since 1997 we have published 266 protocols, 193 new 
reviews and 158 updated reviews (Table). The majority of these reviews are reviews of 
intervention effectiveness; three reviews are diagnostic test accuracy reviews. Overall 18% 
of reviews contain no trials, highlighting a potential evidence gap. The median number of 
trials included in non-empty reviews is 5 (range 1 to 137).   
 [Table here] 
Methods research 
Since 2002, Cochrane Eyes and Vision US satellite has carried out critical methodologic 
research related to systematic reviews. This research has engaged clinical partners and 
addresses topics highly relevant to producing high quality reviews. Investigators at Cochrane 
Eyes and Vision US satellite have published methods papers on prioritizing reviews [13-16],  
practice guidelines [17-19], identifying clinical trials [20], strengths and limitations of data 
sources [21-24], and outcomes in Eyes and Vision trials and reviews [25-29], dissemination 
by co-publication [30], and network meta-analysis methods as applied to open angle 
glaucoma [31 32].  
Cochrane Eyes and Vision Partnerships 
Academic partnerships including guideline panels 
Cochrane Eyes and Vision US satellite has worked with the American Academy of 
Ophthalmology to update their preferred practice guidelines [18 19] and partnered with 
other professional organisations such as  American Academy of Optometry and American 
Optometric Association. The US satellite has provided collaborative educational programs 
hosted by a number of academic institutions and pioneered the concept of Cochrane Eyes 
and Vision Centre for Evidence-based Vision care accreditation for medical centres 
undertaking Cochrane reviews. The Cochrane Eyes and Vision UK editorial base had a formal 
collaboration with the National Institute for Health and Care Excellence (NICE). As part of 
this collaboration we produced a series of review and review updates within a timeframe to 
support the production of their guidelines on macular degeneration and cataract. We also 
have links with the Royal College of Ophthalmologists and College of Optometrists.   
Patients 
Cochrane Eyes and Vision works with individuals affiliated with patient and consumer 
groups. These patient and consumer partners have the opportunity to participate in 
prioritising questions to be addressed by our systematic reviews. They also contribute to 
developing systematic review protocols and the systematic reviews themselves, specifically 
in ensuring that the questions asked and the outcomes that matter to them are addressed. 
Patient partners also serve as peer reviewers, providing their comments to reviews before 
publication. An important role for patient contributors is to advise on appropriate language 
to be used in plain language summaries, contributing to social media exchanges.  
Eyes and vision journals 
Cochrane Eyes and Vision has partnered with Eyes and Vision journals to increase the 
quality of systematic reviews published in traditional journals. The model was put in place in 
2011, when Tianjing Li was appointed as Associate Editor for Systematic Reviews for 
Ophthalmology. The Editor-in-Chief (Dr. George Bartley) and Dr. Li developed guidance for 
authors submitting such manuscripts, and have instituted new quality standards. Similar 
agreements have now been reached with the American Journal of Ophthalmology, BMC 
Ophthalmology, Current Eye Research, Eye, JAMA Ophthalmology, Journal of Glaucoma, 
Retina, Ophthalmic Epidemiology, Ophthalmology Glaucoma, Optometry and Vision Science. 
Dissemination 
Cochrane Eyes and Vision disseminates its reviews by working with guideline panels co-
ordinated by NICE,  American Academy of Ophthalmology, Royal College of 
Ophthalmologists and the College of Optometrists. We encourage review author teams co-
publish their Cochrane reviews in other journals [30] or write articles on the implications of 
the reviews [33]. We prepare a plain language summary for each review and a visual 
summary or blogshot (https://eyes.cochrane.org/blogshots ) along with other teaching 
materials, such as slidesets. Going forward, we will be editing the relevant Wikipedia page 
once each review is published. Our review author teams are encouraged to involve patients 
and the public in their reviews. Cochrane has an active consumer network 
(https://consumers.cochrane.org/).  We are active on social media (@cochraneeyes).   
Cochrane Eyes and Vision US satellite is evaluating novel dissemination techniques such as 
creating 3 to 5 minute YouTube videos. Each video describes the results of a Cochrane Eyes 
and Vision review using plain language narratives and animated graphics.  
Cochrane Corner in Eye 
If health care providers and patients are to make well-informed decisions about their vision 
care, then we must produce systematic reviews of the evidence with all due speed. 
Cochrane Eyes and Vision aims to prepare and promote access to systematic reviews of 
interventions for preventing or treating eye conditions and/or visual impairment, and 
helping people adjust to visual impairment or blindness. As part of our dissemination 
activities, we have teamed up with Eye and will be publishing a ‘Cochrane Corner’ at regular 
intervals in the journal. This will consist of an abstract of a published review with an invited 
clinical commentary on the implications of the review. We are excited about the 
opportunity of publishing summaries of Cochrane systematic review findings in the journal 
Eye. This partnership will allow us to make high quality evidence available for a broad range 
of patients, practitioners, researchers, and policy makers. It will provide an important route 
to ensure that the findings of our reviews are disseminated to clinicians making decisions 
about eye health care.  
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Table: Cochrane Eyes and Vision new reviews, updated reviews and protocols 
 
Year 
Protoco
ls 
New 
reviews 
Update
d 
reviews  
Most 
recent 
update 
of 
review  
Empty  
reviews 
(latest 
update) 
* 
 
Median 
(range) 
studies 
included
** 
(latest 
update) 
What is a systematic review?  
“A Systematic Review is a review of a clearly formulated question that uses systematic 
and reproducible methods to identify, select and critically appraise all relevant 
research, and to collect and analyse data from the studies that are included in the 
review. A systematic review can be either quantitative or qualitative.” 
http://libguides.library.curtin.edu.au/c.php?g=202420&p=1332858  
1997 to 
2004 
64 
(24%) 
27 
(14%) 
12 (8%) 1 
(0.5%) 
0  8  
2005 to 
2009 
77 
(29%) 
50 
(26%) 
35 
(22%) 
17 (9%) 2 (12%) 4 (1 to 
53) 
 
2010 to 
2014 
84 
(32%) 
50 
(26%) 
75 
(47%) 
74 
(38%) 
16 
(22%) 
4 (1 to 
42) 
2015 to 
2018 
41 
(15%) 
66 
(34%) 
36 
(23%) 
101 
(52%) 
16 
(16%) 
6 (1 to 
137) 
Total 266 
(100%) 
193 
(100%) 
158 
(100%) 
193 
(100%) 
34  
(18%) 
5 (1 to 
137) 
 
* As a percentage of total number of reviews 
** Excluding empty reviews 
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